Skip to content

Telehealth in Motor Neurone Disease: a single-centre, randomised controlled feasibility and pilot study of the use of the TiM telehealth system to deliver highly specialised care in Motor Neurone Disease, at a distance

Telehealth in Motor Neurone Disease: a single-centre, randomised controlled feasibility and pilot study of the use of the TiM telehealth system to deliver highly specialised care in Motor Neurone Disease, at a distance

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN26675465
Enrollment
80
Registered
2014-09-05
Start date
2014-09-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Dementias and neurodegeneration

Interventions

This is a randomised controlled pilot study that will involve 40 patients who are cared for by the Sheffield Motor Neurone Disease care centre and their main informal carer. Half of the participants w

Sponsors

Sheffield Teaching Hospitals NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 years or over with ElEscorial clinically definite or clinically probable categories of MND who have attended the MND clinic at the Royal Hallamshire Hospital, Sheffield 2. Live within 120 minute drive from Sheffield

Exclusion criteria

Exclusion criteria: The main circumstances where patients or carers will be excluded are those in which individuals would be unable to use the telehealth system or give informed consent. 1. Patients attend another MND care centre in the UK. 2. Significant impairment in decision making capacity preventing informed consent by the subject due to a major mental disorder including frontotemporal dementia. 3. Patient unable to use the system due to physical, intellectual or language difficulties and unwilling to permit carer to operate it on their behalf 4. The patient has no eligible informal carer willing to participate in the trial 5. No available mobile or landline telephone or 3G mobile phone reception at the patient?s home (this is required to use the TiM system) 6. Any other major impairment that may affect their ability to participate in the study

Design outcomes

Primary

MeasureTime frame
Feasibility and acceptability; Timepoint(s): End of the trial

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 20, 2026